SCHEMBL22345518

SCHEMBL22345518

CCOP(=O)(CC)c1cnnc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ LMNA P02545 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ AOX1 Q06278 1/20 0.35
▸ NR1I2 O75469 1/20 0.35
▸ UTRN P46939 2/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.34
▸ NPY5R Q15761 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ GPR3 P46089 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22345431 0.85 MEN1 (0.42) MEN1KMT2ALMNAHPGDKDM4E
SCHEMBL22345562 0.75 NPY5R (0.44) MEN1KMT2ALMNAHPGDKDM4E
SCHEMBL22345382 0.75 GPR3 (0.39) KMT2ALMNAHPGDKDM4EAOX1
SCHEMBL22345395 0.74 NR1I2 (0.38) MEN1KMT2ALMNAHPGDKDM4E
Iodide SCHEMBL22345479 0.74 KMT2A (0.34) MEN1KMT2ALMNAHPGDKDM4E
SCHEMBL22345378 0.73 KDM4E (0.38) MEN1KMT2ALMNAHPGDKDM4E
SCHEMBL22345497 0.72 ALDH1A1 (0.36) MEN1KMT2ALMNAHPGDKDM4E
SCHEMBL10742424 0.72 GPR3 (0.41) MEN1KMT2ALMNAALDH1A1GPR3
SCHEMBL22345426 0.71 CYP1A2 (0.38) CYP1A2ALDH1A1GPR3SMN1; SMN2
SCHEMBL9114839 0.69 GPR3 (0.46) MEN1KMT2ALMNAHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2022-05-05 — — US disclosed
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2022-05-05 — — US disclosed
EP-3924344-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH Syngenta Crop Protection AG (CH) 2021-12-22 — — EP disclosed
CN-113423694-A Cinnolinium compounds for use in a method for controlling unwanted plant growth 先正达农作物保护股份公司 2021-09-21 — — CN disclosed
WO-2020164970-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2020-08-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH NOTUM, DDT, CYP51A1 MEN1 603/4885KMT2A 3742/4885LMNA 3064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback